CN101190890A - 5-[(2r)-[2-[2-[2-(2,2,2-三氟乙氧基)苯氧基]乙基]氨基]丙基]-2-甲氧基苯磺酰胺 - Google Patents
5-[(2r)-[2-[2-[2-(2,2,2-三氟乙氧基)苯氧基]乙基]氨基]丙基]-2-甲氧基苯磺酰胺 Download PDFInfo
- Publication number
- CN101190890A CN101190890A CNA2006101633172A CN200610163317A CN101190890A CN 101190890 A CN101190890 A CN 101190890A CN A2006101633172 A CNA2006101633172 A CN A2006101633172A CN 200610163317 A CN200610163317 A CN 200610163317A CN 101190890 A CN101190890 A CN 101190890A
- Authority
- CN
- China
- Prior art keywords
- compound
- preparation
- present
- formula
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (6)
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006101633172A CN101190890B (zh) | 2006-11-30 | 2006-11-30 | 5-[(2r)-[2-[2-[2-(2,2,2-三氟乙氧基)苯氧基]乙基]氨基]丙基]-2-甲氧基苯磺酰胺 |
EP07817119A EP2098503A4 (en) | 2006-11-30 | 2007-10-19 | 5 - [(2R) - [2- [2- [2- (2,2,2-trifluoroethoxy) phenoxy] ethyl] amino] propyl] -2-methoxybenzenesulfonamide |
JP2009538576A JP2010510995A (ja) | 2006-11-30 | 2007-10-19 | 5−[(2r)−[2−[2−[2−(2,2,2−トリフルオロエトキシ)フェノキシ]エチル]アミノ]プロピル]−2−メトキシベンゼンスルホンアミド |
BRPI0719391-2A2A BRPI0719391A2 (pt) | 2006-11-30 | 2007-10-19 | 5-[(2r)-[2-[2-[2-(2,2,2-trifluoroetóxi)fenóxi]-etil]amino]p ropil]-2-metoxibenze-nossulfonamida |
AU2007327231A AU2007327231A1 (en) | 2006-11-30 | 2007-10-19 | 5-[(2R)-[2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl)-2-methoxybenzenesulfonamide |
US12/513,033 US20100069668A1 (en) | 2006-11-30 | 2007-10-19 | 5-[(2r)-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-2-methoxybenzenesulfonamide |
CA002668124A CA2668124A1 (en) | 2006-11-30 | 2007-10-19 | 5-[(2r)-[2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-2-methoxybenzenesulfonamide |
KR1020097010458A KR20090085069A (ko) | 2006-11-30 | 2007-10-19 | 5―[(2r)―[2―[2―[2―(2,2,2―트리플루오로에톡시)펜옥시]에틸]아미노]프로필]―2―메톡시벤젠설폰아미드 |
PCT/CN2007/070928 WO2008064595A1 (fr) | 2006-11-30 | 2007-10-19 | 5-[(2r)-[2-[2-[2-(2,2,2-trifluoroéthoxy)phénoxy]éthyl]amino]propyl]-2-méthoxybenzenesulfonamide |
RU2009119869/04A RU2009119869A (ru) | 2006-11-30 | 2007-10-19 | 5-[(2r)-[2-[2-[2-(2,2,2-трифторэтокси)фенокси]этил]амино]пропил]-2-метоксибензолсульфонамид |
MX2009005482A MX2009005482A (es) | 2006-11-30 | 2007-10-19 | 5-[(2r)-[2-[2-[2-(2,2,2,-trifluoroetoxi)fenoxi]etil]amino]propil] -2-metoxibencensulfonamida. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006101633172A CN101190890B (zh) | 2006-11-30 | 2006-11-30 | 5-[(2r)-[2-[2-[2-(2,2,2-三氟乙氧基)苯氧基]乙基]氨基]丙基]-2-甲氧基苯磺酰胺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101190890A true CN101190890A (zh) | 2008-06-04 |
CN101190890B CN101190890B (zh) | 2011-04-27 |
Family
ID=39467444
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006101633172A Expired - Fee Related CN101190890B (zh) | 2006-11-30 | 2006-11-30 | 5-[(2r)-[2-[2-[2-(2,2,2-三氟乙氧基)苯氧基]乙基]氨基]丙基]-2-甲氧基苯磺酰胺 |
Country Status (11)
Country | Link |
---|---|
US (1) | US20100069668A1 (zh) |
EP (1) | EP2098503A4 (zh) |
JP (1) | JP2010510995A (zh) |
KR (1) | KR20090085069A (zh) |
CN (1) | CN101190890B (zh) |
AU (1) | AU2007327231A1 (zh) |
BR (1) | BRPI0719391A2 (zh) |
CA (1) | CA2668124A1 (zh) |
MX (1) | MX2009005482A (zh) |
RU (1) | RU2009119869A (zh) |
WO (1) | WO2008064595A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111513273A (zh) * | 2020-04-01 | 2020-08-11 | 陕西理工大学 | 一种魔芋功能食品及其制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3511836A (en) * | 1967-12-13 | 1970-05-12 | Pfizer & Co C | 2,4,6,7-tetra substituted quinazolines |
US4026894A (en) | 1975-10-14 | 1977-05-31 | Abbott Laboratories | Antihypertensive agents |
US4188390A (en) * | 1977-11-05 | 1980-02-12 | Pfizer Inc. | Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines |
FR2421888A1 (fr) | 1978-02-06 | 1979-11-02 | Synthelabo | Amides d'alkylene-diamines et leur application en therapeutique |
JPS56110665A (en) * | 1980-02-08 | 1981-09-01 | Yamanouchi Pharmaceut Co Ltd | Sulfamoyl-substituted phenetylamine derivative and its preparation |
JPH066565B2 (ja) | 1986-07-21 | 1994-01-26 | 山之内製薬株式会社 | 光学活性なベンゼンスルホンアミド誘導体の製造法 |
EP0600675B1 (en) * | 1992-12-02 | 1998-07-08 | Kissei Pharmaceutical Co., Ltd. | Indoline compounds for the treatment of dysuria |
WO2004087623A2 (en) * | 2003-03-07 | 2004-10-14 | Alembic Limited | An improved process for the preparation of (r) (-) tamsulosin hydrochloride |
JP4800213B2 (ja) * | 2004-07-07 | 2011-10-26 | 浜理薬品工業株式会社 | 光学活性フェニルプロピルアミン誘導体の製法 |
-
2006
- 2006-11-30 CN CN2006101633172A patent/CN101190890B/zh not_active Expired - Fee Related
-
2007
- 2007-10-19 BR BRPI0719391-2A2A patent/BRPI0719391A2/pt not_active IP Right Cessation
- 2007-10-19 EP EP07817119A patent/EP2098503A4/en not_active Withdrawn
- 2007-10-19 JP JP2009538576A patent/JP2010510995A/ja not_active Withdrawn
- 2007-10-19 KR KR1020097010458A patent/KR20090085069A/ko not_active Application Discontinuation
- 2007-10-19 CA CA002668124A patent/CA2668124A1/en not_active Abandoned
- 2007-10-19 AU AU2007327231A patent/AU2007327231A1/en not_active Abandoned
- 2007-10-19 RU RU2009119869/04A patent/RU2009119869A/ru unknown
- 2007-10-19 MX MX2009005482A patent/MX2009005482A/es active IP Right Grant
- 2007-10-19 WO PCT/CN2007/070928 patent/WO2008064595A1/zh active Application Filing
- 2007-10-19 US US12/513,033 patent/US20100069668A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2007327231A1 (en) | 2008-06-05 |
MX2009005482A (es) | 2009-06-08 |
CA2668124A1 (en) | 2008-06-05 |
EP2098503A1 (en) | 2009-09-09 |
WO2008064595A1 (fr) | 2008-06-05 |
EP2098503A4 (en) | 2010-02-10 |
US20100069668A1 (en) | 2010-03-18 |
RU2009119869A (ru) | 2011-01-10 |
CN101190890B (zh) | 2011-04-27 |
KR20090085069A (ko) | 2009-08-06 |
BRPI0719391A2 (pt) | 2014-02-18 |
JP2010510995A (ja) | 2010-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR880001090B1 (ko) | 디피리다몰의 경구용 제형의 제조방법 | |
RU2201754C2 (ru) | Фармацевтический состав, способ его получения, способ лечения психотических состояний и гиперактивности | |
HU211236A9 (en) | Antacide compositions with prolonged gastric residence time | |
US20070155679A1 (en) | Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations | |
EP2116242B1 (en) | New pharmaceutical composition | |
CN106074445B (zh) | 包衣药物球状体及其制备消除或减少病症的药物的用途 | |
PL200957B1 (pl) | Kompozycja farmaceutyczna celecoxib'u i zastosowanie kompozycji farmaceutycznej | |
CN103083319B (zh) | 一种复方缬沙坦氨氯地平固体制剂的制备工艺 | |
KR20080076382A (ko) | 실로스타졸의 제어방출 제제 및 그 제조방법 | |
EA014707B1 (ru) | Новая форма введения рацекадотрила | |
WO2006115770A2 (en) | Orally disintegrating pharmaceutical tablet formulations of olanzapine | |
JPH0625064B2 (ja) | 制御放出塩化カリウム | |
AU748993B2 (en) | Pharmaceutical combinations containing tramadol | |
KR101050015B1 (ko) | 위체류약물전달시스템을 이용한 애엽 추출물의 약학조성물및 이를 이용한 서방성 경구용 제제 | |
CN100427094C (zh) | α-(吗啉-1-基)甲基-2-甲基-5-硝基咪唑-1-乙醇在制备抗滴虫、抗阿米巴原虫药物的用途 | |
CN101190890B (zh) | 5-[(2r)-[2-[2-[2-(2,2,2-三氟乙氧基)苯氧基]乙基]氨基]丙基]-2-甲氧基苯磺酰胺 | |
CN103096880A (zh) | 不愉快味道被掩蔽的含药膜包覆的颗粒 | |
CN102088972A (zh) | 含有咪唑-5-羧酸类衍生物的药用组合物,其制备方法及用途 | |
CN101715448A (zh) | 一种咪唑-5-羧酸衍生物的治疗用途 | |
TW200835525A (en) | Method for improvement of elution | |
WO2003017983A1 (en) | A new extended release oral dosage form | |
JPH0148245B2 (zh) | ||
US20100008956A1 (en) | Composition and combinations of carboxylic acid losartan in dosage forms | |
EA003584B1 (ru) | Способ стимуляции отказа от курения или его снижения или предупреждения возобновления курения и применение пароксетина или его фармацевтически приемлемых солей или сольватов для получения лекарственного средства | |
WO2003017984A1 (en) | A new extended release oral dosage form |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1112679 Country of ref document: HK |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1112679 Country of ref document: HK |
|
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Patentee after: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Patentee before: Jiangsu best Pharmaceutical Co.,Ltd. Address after: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Patentee after: Jiangsu best Pharmaceutical Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Patentee before: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110427 Termination date: 20181130 |
|
CF01 | Termination of patent right due to non-payment of annual fee |